EZH2 and cancer: Based on the EZH2 role in tumorigenesis and stem cell maintenance, studies have been focused on targeting EZH2, a H3K27 methyltransferase, as a novel cancer treatment, and aimed to identify small molecules that inhibit its catalytic activity [5, 6, 40–42].